Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Zymeworks (ZYME) Shares Outstanding (2021 - 2025)

Zymeworks' Shares Outstanding history spans 5 years, with the latest figure at $74.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 8.23% to $74.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $74.6 million, a 8.23% increase, with the full-year FY2025 number at $74.6 million, up 8.23% from a year prior.
  • Shares Outstanding hit $74.6 million in Q4 2025 for Zymeworks, down from $75.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ZYME hit a ceiling of $75.1 million in Q3 2025 and a floor of $1.0 in Q2 2024.
  • Historically, Shares Outstanding has averaged $39.7 million across 5 years, with a median of $57.8 million in 2022.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 7011599600.0% in 2023 and later plummeted 100.0% in 2025.
  • Tracing ZYME's Shares Outstanding over 5 years: stood at $46.6 million in 2021, then crashed by 100.0% to $1.0 in 2022, then skyrocketed by 7011599600.0% to $70.1 million in 2023, then decreased by 1.64% to $69.0 million in 2024, then increased by 8.23% to $74.6 million in 2025.
  • Business Quant data shows Shares Outstanding for ZYME at $74.6 million in Q4 2025, $75.1 million in Q3 2025, and $74.8 million in Q2 2025.